Department of Psychiatry, University of Arkansas for Medical Sciences, Little Rock, AR, USA; Department of Obstetrics & Gynecology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Division of Pharmaceutical Evaluation and Policy, Department of Pharmacy Practice, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Contraception. 2019 May;99(5):296-299. doi: 10.1016/j.contraception.2019.01.004. Epub 2019 Feb 11.
To describe claims for contraceptive services among reproductive-aged women filling chronic opioid prescriptions.
Using a large US commercial claims database, IMS Lifelink+, we identified women aged 15-44 years who filled chronic opioid prescriptions (defined as a 90-day supply of opioids without a 30-day gap over a 180-day time period) and had continuous pharmacy and medical enrollment for at least 90 days prior to and 180 days following their index opioid prescription. After excluding women with any claims for pregnancy-related services, we describe claims for contraceptive prescriptions.
We identified 16,074 women with claims for chronic opioids who had filled an average of 135±28-day supply of opioids over a 180-day period. Of these, 23.4% (n=3759) had a claim for prescription contraception in the 90 days prior or 180 days following their index opioid claim. Of those who had claims for prescription contraception, 70% (n=2642) received oral contraceptives; only 2% had claims related to a long-acting reversible contraceptive (i.e., a contraceptive implant or intrauterine device).
Commercially insured women filling chronic opioid prescriptions may have unmet needs for prescription contraception.
Efforts are needed to ensure that the reproductive health needs of women filling chronic opioid prescriptions are met.
描述在使用慢性阿片类药物处方的育龄妇女中避孕服务的索赔情况。
利用美国大型商业索赔数据库 IMS Lifelink+，我们确定了年龄在 15-44 岁之间的女性，她们有慢性阿片类药物处方（定义为在 180 天的时间段内没有 30 天间隔的 90 天供应量的阿片类药物），并且在其阿片类药物处方的索引之前和之后至少有 90 天的连续药房和医疗登记。在排除任何与妊娠相关服务索赔的女性后，我们描述了避孕处方的索赔情况。
我们确定了 16074 名有慢性阿片类药物索赔的女性，她们在 180 天的时间内平均服用了 135±28 天的阿片类药物。其中，23.4%（n=3759）在索引阿片类药物索赔前 90 天或后 180 天内有处方避孕的索赔。在那些有处方避孕索赔的人中，70%（n=2642）接受了口服避孕药；只有 2%有与长效可逆避孕相关的索赔（即避孕植入物或宫内节育器）。
服用慢性阿片类药物处方的商业保险女性可能有未满足的处方避孕需求。
需要努力确保满足服用慢性阿片类药物处方的女性的生殖健康需求。
